In conclusion, MNs/GLP-1RAs@NPs-WYRGRL did not show obvious toxicity in long-term treatment, indicating its good biological safety and suggesting it as a safe and effective treatment strategy for RA
Recently, the pharmacotherapy of MASLD mainly focuses on three parts of mechanisms: anti-inflammatory (ASK1 inhibitors), anti-diabetic (GCGR agonists, PPAR agonists), and prevention of lipotoxicity (FXR agonists, FGF21 analogues) (Wei et al., 2024)
Nevertheless, ongoing surveillance and research are important to fully characterize long-term safety as use of this therapy expands
RESULT: Your face look fair and white, smooth, fresh and younger
Moreover, downregulation of IGF-1R, obtained by antisense strategies, has been reported to elicit a host response leading to eradication of surviving malignant cells in vivo (Resnicoff et al, 1996)
Using a GLP-1